Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
On The Fly
Wall Street in Fives - Must Read Lists for Wednesday » 16:24
06/02/21
06/02
16:24
06/02/21
16:24
AMZN

Amazon.com

$3,235.00 /

+15.72 (+0.49%)

, ETSY

Etsy

$175.03 /

+11.67 (+7.14%)

, MOR

MorphoSys

$19.20 /

-2.94 (-13.28%)

, CNST

Constellation Pharmaceuticals

$33.53 /

+13.28 (+65.58%)

, FB

Facebook

$329.12 /

+0.13 (+0.04%)

, AMC

AMC Entertainment

$63.94 /

+31.95 (+99.87%)

, CNK

Cinemark

$24.97 /

+0.55 (+2.25%)

, IMAX

Imax

$21.98 /

-0.305 (-1.37%)

, HNST

Honest Company

$19.19 /

+2.34 (+13.89%)

, VMEO

Vimeo

$40.80 /

-2.04 (-4.76%)

, CGC

Canopy Growth

$25.57 /

+1.26 (+5.18%)

, TSLA

Tesla

$604.98 /

-18.77 (-3.01%)

, OSTK

Overstock.com

$93.39 /

+7.74 (+9.04%)

, CS

Credit Suisse

$11.11 /

-0.03 (-0.27%)

, DBX

Dropbox

$27.85 /

+1.04 (+3.88%)

, SKLZ

Skillz

$21.57 /

+4.58 (+26.96%)

, BBBY

Bed Bath & Beyond

$44.22 /

+16.975 (+62.31%)

, WPRT

Westport

$5.88 /

-0.875 (-12.96%)

, SESN

Sesen Bio

$3.70 /

-0.16 (-4.15%)

, IRTC

iRhythm

$62.72 /

-13.48 (-17.69%)

, ZM

Zoom Video

$326.98 /

-0.84 (-0.26%)

, MDLA

Medallia

$27.47 /

+2.42 (+9.66%)

, ITII

ITI Technologies

/

+

, HPE

HP Enterprise

$16.07 /

-0.01 (-0.06%)

, PROG

Progenity

$2.19 /

-0.66 (-23.16%)

Get caught up quickly on…

ShowHide Related Items >><<
ZM Zoom Video
$326.98 /

-0.84 (-0.26%)

WPRT Westport
$5.88 /

-0.875 (-12.96%)

VMEO Vimeo
$40.80 /

-2.04 (-4.76%)

TSLA Tesla
$604.98 /

-18.77 (-3.01%)

SKLZ Skillz
$21.57 /

+4.58 (+26.96%)

SESN Sesen Bio
$3.70 /

-0.16 (-4.15%)

PROG Progenity
$2.19 /

-0.66 (-23.16%)

OSTK Overstock.com
$93.39 /

+7.74 (+9.04%)

MOR MorphoSys
$19.20 /

-2.94 (-13.28%)

MDLA Medallia
$27.47 /

+2.42 (+9.66%)

IRTC iRhythm
$62.72 /

-13.48 (-17.69%)

IMAX Imax
$21.98 /

-0.305 (-1.37%)

HPE HP Enterprise
$16.07 /

-0.01 (-0.06%)

FB Facebook
$329.12 /

+0.13 (+0.04%)

ETSY Etsy
$175.03 /

+11.67 (+7.14%)

DBX Dropbox
$27.85 /

+1.04 (+3.88%)

CS Credit Suisse
$11.11 /

-0.03 (-0.27%)

CNST Constellation Pharmaceuticals
$33.53 /

+13.28 (+65.58%)

CNK Cinemark
$24.97 /

+0.55 (+2.25%)

CGC Canopy Growth
$25.57 /

+1.26 (+5.18%)

BBBY Bed Bath & Beyond
$44.22 /

+16.975 (+62.31%)

AMZN Amazon.com
$3,235.00 /

+15.72 (+0.49%)

AMC AMC Entertainment
$63.94 /

+31.95 (+99.87%)

AMZN Amazon.com
$3,235.00 /

+15.72 (+0.49%)

06/02/21 Morgan Stanley
Morgan Stanley sees signs of broader same-day shipping coming from Amazon
05/27/21 Evercore ISI
Evercore survey shows Amazon one of the biggest Covid beneficiaries
05/27/21 Stifel
Stifel sees 'minimal impact' to Netflix from Amazon's MGM acquisition
05/27/21 Benchmark
Streaming field 'looking ever less unipolar around Netflix,' says Benchmark
ETSY Etsy
$175.03 /

+11.67 (+7.14%)

06/03/21 KeyBanc
Etsy's acquisition of Depop 'fits well,' says KeyBanc
06/02/21 Canaccord
Canaccord says Etsy adds 'another differentiated and well-run platform' in Depop
06/02/21 Roth Capital
Etsy acquisition expands youth reach, says Roth Capital
06/02/21 Stifel
Etsy 'smartly expanding' with Depop acquisition, says Stifel
MOR MorphoSys
$19.20 /

-2.94 (-13.28%)

06/03/21 Bryan Garnier
MorphoSys downgraded to Neutral from Buy at Bryan Garnier
06/03/21 SVB Leerink
MorphoSys upgraded to Outperform from Market Perform at SVB Leerink
06/03/21 Bryan Garnier
MorphoSys downgraded to Neutral from Buy at Bryan Garnier
05/24/21 Morgan Stanley
Morgan Stanley upgrades MorphoSys with shares near 'bear case value'
CNST Constellation Pharmaceuticals
$33.53 /

+13.28 (+65.58%)

06/03/21 Cowen
Constellation Pharmaceuticals downgraded to Market Perform from Outperform at Cowen
06/02/21 BMO Capital
Constellation Pharmaceuticals downgraded to Market Perform at BMO Capital
06/02/21 Baird
Constellation Pharmaceuticals downgraded to Neutral from Outperform at Baird
06/02/21 JPMorgan
Constellation Pharmaceuticals downgraded to Neutral from Overweight at JPMorgan
FB Facebook
$329.12 /

+0.13 (+0.04%)

06/02/21 KGI Securities
Facebook initiated with an Outperform at KGI Securities
05/25/21 HSBC
Facebook price target raised to $275 from $220 at HSBC
05/10/21
Fly Intel: Top five analyst downgrades
05/10/21 Citi
Facebook downgraded at Citi with Google on concerns over expectations
AMC AMC Entertainment
$63.94 /

+31.95 (+99.87%)

06/01/21 Loop Capital
AMC Entertainment remains massively diluted, overlevered, says Loop Capital
05/26/21
Fly Intel: Top five analyst downgrades
05/26/21 B. Riley
AMC Entertainment downgraded to Neutral from Buy at B. Riley
05/25/21 Citi
Citi boosts AMC target to $3.70, says shares remain overvalued
CNK Cinemark
$24.97 /

+0.55 (+2.25%)

06/02/21 Goldman Sachs
Cinemark downgraded to Sell from Neutral at Goldman Sachs
04/19/21 Morgan Stanley
Cinemark price target raised to $25 from $17 at Morgan Stanley
03/24/21 B. Riley
Disney 'day-and-date' decision negative for exhibitors, says B. Riley
03/03/21 Barrington
Cinemark price target raised to $26 from $22 at Barrington
IMAX Imax
$21.98 /

-0.305 (-1.37%)

06/02/21
Fly Intel: Top five analyst downgrades
06/02/21 Goldman Sachs
Imax downgraded to Sell from Neutral at Goldman Sachs
05/24/21 Benchmark
Imax price target raised to $25 at Benchmark after F9's opening weekend
04/30/21 Macquarie
Imax price target raised to $30 from $25 at Macquarie
HNST Honest Company
$19.19 /

+2.34 (+13.89%)

06/02/21 BofA
Honest Company initiated with a Neutral at BofA
06/01/21
Fly Intel: Top five analyst initiations
06/01/21 William Blair
Honest Company initiated with an Outperform at William Blair
06/01/21 Jefferies
Honest Company initiated with a Buy at Jefferies
VMEO Vimeo
$40.80 /

-2.04 (-4.76%)

06/03/21 Piper Sandler
Vimeo initiated with an Overweight at Piper Sandler
06/02/21
Fly Intel: Top five analyst initiations
06/02/21 Cowen
Cowen sees Vimeo as rising video SaaS star, starts with Outperform
06/02/21 Cowen
Vimeo initiated with an Outperform at Cowen
CGC Canopy Growth
$25.57 /

+1.26 (+5.18%)

06/02/21 CIBC
Canopy Growth price target lowered to C$36 from C$38 at CIBC
06/02/21
Fly Intel: Top five analyst upgrades
06/02/21 MKM Partners
Canopy Growth price target lowered to C$51 from C$55 at MKM Partners
06/02/21 Eight Capital
Canopy Growth upgraded to Neutral from Sell at Eight Capital
TSLA Tesla
$604.98 /

-18.77 (-3.01%)

06/02/21 Morgan Stanley
Oil price rise 'significantly improves' EV payback math, says Morgan Stanley
05/24/21
Fly Intel: Top five analyst initiations
05/24/21 Wells Fargo
Tesla initiated with an Equal Weight at Wells Fargo
05/21/21 BofA
Tesla price target lowered to $700 from $900 at BofA
OSTK Overstock.com
$93.39 /

+7.74 (+9.04%)

05/18/21 Credit Suisse
Overstock.com assumed with an Outperform at Credit Suisse
05/18/21 Piper Sandler
Overstock.com holders getting tZero upside 'for free,' says Piper Sandler
04/27/21 Piper Sandler
Overstock.com shares still mispriced with 100% upside, says Piper Sandler
04/14/21 Wedbush
Wedbush bullish on Overstock.com, assumes coverage with an Outperform
CS Credit Suisse
$11.11 /

-0.03 (-0.27%)

05/27/21 Barclays
Credit Suisse price target raised to CHF 12.50 from CHF 12 at Barclays
04/28/21 UBS
Credit Suisse upgraded to Buy from Neutral at UBS
04/28/21 UBS
Credit Suisse upgraded to Buy from Neutral at UBS
04/23/21 Societe Generale
Credit Suisse price target lowered to CHF 10 from CHF 11 at Societe Generale
DBX Dropbox
$27.85 /

+1.04 (+3.88%)

05/14/21 Goldman Sachs
Dropbox initiated with a Sell at Goldman Sachs
03/15/21 Jefferies
Dropbox price target raised to $31 from $28 at Jefferies
03/04/21 Citi
Citi adds Medallia to 'Value Creators' list, removes Dropbox
01/14/21 Canaccord
Dropbox sustainable growth questions remain, says Canaccord
SKLZ Skillz
$21.57 /

+4.58 (+26.96%)

05/21/21 Citi
Skillz price target lowered to $23 from $27 at Citi
05/06/21 Wells Fargo
Skillz price target lowered to $18.50 from $28 at Wells Fargo
05/05/21 Canaccord
Skillz price target lowered to $30 from $33 at Canaccord
05/05/21 Canaccord
Skillz price target lowered to $30 from $33 at Canaccord
BBBY Bed Bath & Beyond
$44.22 /

+16.975 (+62.31%)

05/18/21 Credit Suisse
Bed Bath & Beyond assumed with a Neutral at Credit Suisse
04/19/21 JPMorgan
Bed Bath & Beyond price target raised to $29 from $23 at JPMorgan
04/16/21 Loop Capital
Bed Bath & Beyond price target lowered to $24 from $30 at Loop Capital
04/15/21 Wedbush
Bed Bath & Beyond price target lowered to $27 from $33 at Wedbush
WPRT Westport
$5.88 /

-0.875 (-12.96%)

03/18/21 Lake Street
Lake Street confidence in Westport's China ramp boosted by Weichai deal
03/17/21 H.C. Wainwright
Westport price target raised to $16 from $5 at H.C. Wainwright
02/08/21 Craig-Hallum
Clean Energy price target raised to $25 from $12 at Craig-Hallum
02/08/21 Craig-Hallum
Westport target raised to $24 following Amazon truck order, says Craig-Hallum
SESN Sesen Bio
$3.70 /

-0.16 (-4.15%)

02/17/21 Canaccord
Sesen Bio price target raised to $7 from $5 at Canaccord
02/16/21 Canaccord
Sesen Bio price target raised to $7 from $5 at Canaccord
02/16/21 Jefferies
Jefferies doubles target on Sesen Bio to $6 on 'optimal scenario'
01/25/21 Canaccord
Sesen Bio a must-own small cap for 2021, says Canaccord
IRTC iRhythm
$62.72 /

-13.48 (-17.69%)

06/02/21 Citi
iRhythm downgraded to Neutral from Buy at Citi
04/14/21 Morgan Stanley
iRhythm downgraded to Equal Weight from Overweight at Morgan Stanley
04/13/21 Truist
iRhythm price target lowered to $115 from $220 at Truist
04/13/21 BTIG
iRhythm downgraded to Neutral from Buy at BTIG
ZM Zoom Video
$326.98 /

-0.84 (-0.26%)

06/02/21 JPMorgan
Zoom Video price target lowered to $385 from $456 at JPMorgan
06/02/21 Morgan Stanley
Zoom Video churn overhang keeps near-term ceiling on shares, says Morgan Stanley
06/02/21 BTIG
Zoom Video price target lowered to $495 from $550 at BTIG
06/02/21 Deutsche Bank
Zoom Video price target raised to $375 from $360 at Deutsche Bank
MDLA Medallia
$27.47 /

+2.42 (+9.66%)

06/02/21 BTIG
Medallia price target lowered to $42 from $49 at BTIG
06/02/21 Craig-Hallum
Medallia price target lowered to $35 from $44 at Craig-Hallum
06/02/21 BofA
Medallia price target lowered to $43 from $49 at BofA
06/02/21 Citi
Medallia price target lowered to $50 from $59 at Citi
ITII ITI Technologies
/

+

HPE HP Enterprise
$16.07 /

-0.01 (-0.06%)

06/02/21 Loop Capital
HP Enterprise price target raised to $15 from $11 at Loop Capital
06/02/21 Stifel
HP Enterprise guidance reflects supply constraints, says Stifel
06/02/21 Deutsche Bank
HP Enterprise price target raised to $18 from $17 at Deutsche Bank
06/02/21 Barclays
HP Enterprise price target raised to $16 from $15 at Barclays
PROG Progenity
$2.19 /

-0.66 (-23.16%)

06/03/21 Raymond James
Progenity downgraded to Market Perform from Outperform at Raymond James
06/03/21 Baird
Baird downgrades Progenity, halves target, on 'abrupt end' to core
06/03/21 Piper Sandler
Progenity price target lowered to $3 from $8 at Piper Sandler
06/03/21 Baird
Progenity downgraded to Neutral from Outperform at Baird
ZM Zoom Video
$326.98 /

-0.84 (-0.26%)

WPRT Westport
$5.88 /

-0.875 (-12.96%)

TSLA Tesla
$604.98 /

-18.77 (-3.01%)

SKLZ Skillz
$21.57 /

+4.58 (+26.96%)

SESN Sesen Bio
$3.70 /

-0.16 (-4.15%)

PROG Progenity
$2.19 /

-0.66 (-23.16%)

OSTK Overstock.com
$93.39 /

+7.74 (+9.04%)

MDLA Medallia
$27.47 /

+2.42 (+9.66%)

IRTC iRhythm
$62.72 /

-13.48 (-17.69%)

IMAX Imax
$21.98 /

-0.305 (-1.37%)

HPE HP Enterprise
$16.07 /

-0.01 (-0.06%)

FB Facebook
$329.12 /

+0.13 (+0.04%)

ETSY Etsy
$175.03 /

+11.67 (+7.14%)

DBX Dropbox
$27.85 /

+1.04 (+3.88%)

CS Credit Suisse
$11.11 /

-0.03 (-0.27%)

CNST Constellation Pharmaceuticals
$33.53 /

+13.28 (+65.58%)

CNK Cinemark
$24.97 /

+0.55 (+2.25%)

CGC Canopy Growth
$25.57 /

+1.26 (+5.18%)

BBBY Bed Bath & Beyond
$44.22 /

+16.975 (+62.31%)

AMZN Amazon.com
$3,235.00 /

+15.72 (+0.49%)

AMC AMC Entertainment
$63.94 /

+31.95 (+99.87%)

  • 03
    Jun
  • 05
    May
  • 19
    Mar
  • 13
    Jan
  • 03
    Dec
  • 19
    Aug
  • 12
    Aug
  • 17
    Jun
  • 19
    Jun
ZM Zoom Video
$326.98 /

-0.84 (-0.26%)

WPRT Westport
$5.88 /

-0.875 (-12.96%)

TSLA Tesla
$604.98 /

-18.77 (-3.01%)

SKLZ Skillz
$21.57 /

+4.58 (+26.96%)

OSTK Overstock.com
$93.39 /

+7.74 (+9.04%)

IRTC iRhythm
$62.72 /

-13.48 (-17.69%)

IMAX Imax
$21.98 /

-0.305 (-1.37%)

HPE HP Enterprise
$16.07 /

-0.01 (-0.06%)

HNST Honest Company
$19.19 /

+2.34 (+13.89%)

FB Facebook
$329.12 /

+0.13 (+0.04%)

ETSY Etsy
$175.03 /

+11.67 (+7.14%)

DBX Dropbox
$27.85 /

+1.04 (+3.88%)

CS Credit Suisse
$11.11 /

-0.03 (-0.27%)

CNK Cinemark
$24.97 /

+0.55 (+2.25%)

CGC Canopy Growth
$25.57 /

+1.26 (+5.18%)

BBBY Bed Bath & Beyond
$44.22 /

+16.975 (+62.31%)

AMZN Amazon.com
$3,235.00 /

+15.72 (+0.49%)

AMC AMC Entertainment
$63.94 /

+31.95 (+99.87%)

WPRT Westport
$5.88 /

-0.875 (-12.96%)

VMEO Vimeo
$40.80 /

-2.04 (-4.76%)

TSLA Tesla
$604.98 /

-18.77 (-3.01%)

SKLZ Skillz
$21.57 /

+4.58 (+26.96%)

SESN Sesen Bio
$3.70 /

-0.16 (-4.15%)

PROG Progenity
$2.19 /

-0.66 (-23.16%)

OSTK Overstock.com
$93.39 /

+7.74 (+9.04%)

MOR MorphoSys
$19.20 /

-2.94 (-13.28%)

MDLA Medallia
$27.47 /

+2.42 (+9.66%)

HNST Honest Company
$19.19 /

+2.34 (+13.89%)

FB Facebook
$329.12 /

+0.13 (+0.04%)

ETSY Etsy
$175.03 /

+11.67 (+7.14%)

DBX Dropbox
$27.85 /

+1.04 (+3.88%)

CS Credit Suisse
$11.11 /

-0.03 (-0.27%)

BBBY Bed Bath & Beyond
$44.22 /

+16.975 (+62.31%)

AMZN Amazon.com
$3,235.00 /

+15.72 (+0.49%)

AMC AMC Entertainment
$63.94 /

+31.95 (+99.87%)

ZM Zoom Video
$326.98 /

-0.84 (-0.26%)

WPRT Westport
$5.88 /

-0.875 (-12.96%)

TSLA Tesla
$604.98 /

-18.77 (-3.01%)

SKLZ Skillz
$21.57 /

+4.58 (+26.96%)

PROG Progenity
$2.19 /

-0.66 (-23.16%)

OSTK Overstock.com
$93.39 /

+7.74 (+9.04%)

IMAX Imax
$21.98 /

-0.305 (-1.37%)

HPE HP Enterprise
$16.07 /

-0.01 (-0.06%)

HNST Honest Company
$19.19 /

+2.34 (+13.89%)

FB Facebook
$329.12 /

+0.13 (+0.04%)

ETSY Etsy
$175.03 /

+11.67 (+7.14%)

DBX Dropbox
$27.85 /

+1.04 (+3.88%)

CS Credit Suisse
$11.11 /

-0.03 (-0.27%)

CNK Cinemark
$24.97 /

+0.55 (+2.25%)

CGC Canopy Growth
$25.57 /

+1.26 (+5.18%)

BBBY Bed Bath & Beyond
$44.22 /

+16.975 (+62.31%)

AMZN Amazon.com
$3,235.00 /

+15.72 (+0.49%)

AMC AMC Entertainment
$63.94 /

+31.95 (+99.87%)

On The Fly
Wall Street in Fives - Must Read Lists at Midday » 12:05
06/02/21
06/02
12:05
06/02/21
12:05
AMZN

Amazon.com

$3,231.95 /

+12.67 (+0.39%)

, ETSY

Etsy

$170.84 /

+7.48 (+4.58%)

, MOR

MorphoSys

$19.34 /

-2.8 (-12.65%)

, CNST

Constellation Pharmaceuticals

$33.74 /

+13.49 (+66.62%)

, TM

Toyota

$176.43 /

+4.05 (+2.35%)

, TSLA

Tesla

$607.33 /

-16.42 (-2.63%)

, MDLA

Medallia

$28.27 /

+3.215 (+12.83%)

, ITI

Iteris

$7.21 /

+0.01 (+0.14%)

, ZM

Zoom Video

$327.85 /

+0.03 (+0.01%)

, HPE

HP Enterprise

$15.96 /

-0.12 (-0.75%)

, PROG

Progenity

$2.37 /

-0.48 (-16.84%)

, SKLZ

Skillz

$19.60 /

+2.615 (+15.40%)

, BBBY

Bed Bath & Beyond

$37.98 /

+10.735 (+39.40%)

, WPRT

Westport

$6.13 /

-0.62 (-9.19%)

, SESN

Sesen Bio

$3.69 /

-0.175 (-4.53%)

, IRTC

iRhythm

$63.51 /

-12.69 (-16.65%)

, CNK

Cinemark

$23.24 /

-1.18 (-4.83%)

, IMAX

Imax

$21.62 /

-0.665 (-2.98%)

, HNST

Honest Company

$17.82 /

+0.97 (+5.76%)

, VMEO

Vimeo

$42.80 /

-0.04 (-0.09%)

, CGC

Canopy Growth

$25.39 /

+1.08 (+4.44%)

, OSTK

Overstock.com

$88.12 /

+2.47 (+2.88%)

, MSFT

Microsoft

$248.34 /

+1.075 (+0.43%)

, DLB

Dolby

$96.01 /

-0.5 (-0.52%)

, CS

Credit Suisse

$11.10 /

-0.04 (-0.36%)

, SFTBY

SoftBank

$37.23 /

-0.94 (-2.46%)

Get caught up quickly on…

ShowHide Related Items >><<
ZM Zoom Video
$327.85 /

+0.03 (+0.01%)

WPRT Westport
$6.13 /

-0.62 (-9.19%)

VMEO Vimeo
$42.80 /

-0.04 (-0.09%)

TSLA Tesla
$607.33 /

-16.42 (-2.63%)

TM Toyota
$176.43 /

+4.05 (+2.35%)

SKLZ Skillz
$19.60 /

+2.615 (+15.40%)

SFTBY SoftBank
$37.23 /

-0.94 (-2.46%)

SESN Sesen Bio
$3.69 /

-0.175 (-4.53%)

PROG Progenity
$2.37 /

-0.48 (-16.84%)

OSTK Overstock.com
$88.12 /

+2.47 (+2.88%)

MSFT Microsoft
$248.34 /

+1.075 (+0.43%)

MOR MorphoSys
$19.34 /

-2.8 (-12.65%)

MDLA Medallia
$28.27 /

+3.215 (+12.83%)

ITI Iteris
$7.21 /

+0.01 (+0.14%)

IRTC iRhythm
$63.51 /

-12.69 (-16.65%)

IMAX Imax
$21.62 /

-0.665 (-2.98%)

HPE HP Enterprise
$15.96 /

-0.12 (-0.75%)

ETSY Etsy
$170.84 /

+7.48 (+4.58%)

DLB Dolby
$96.01 /

-0.5 (-0.52%)

CS Credit Suisse
$11.10 /

-0.04 (-0.36%)

CNST Constellation Pharmaceuticals
$33.74 /

+13.49 (+66.62%)

CNK Cinemark
$23.24 /

-1.18 (-4.83%)

CGC Canopy Growth
$25.39 /

+1.08 (+4.44%)

BBBY Bed Bath & Beyond
$37.98 /

+10.735 (+39.40%)

AMZN Amazon.com
$3,231.95 /

+12.67 (+0.39%)

AMZN Amazon.com
$3,231.95 /

+12.67 (+0.39%)

05/27/21 Evercore ISI
Evercore survey shows Amazon one of the biggest Covid beneficiaries
05/27/21 Stifel
Stifel sees 'minimal impact' to Netflix from Amazon's MGM acquisition
05/27/21 Benchmark
Streaming field 'looking ever less unipolar around Netflix,' says Benchmark
05/27/21 Mizuho
CVS, Walgreens selloff on Amazon report overdone, says Mizuho
ETSY Etsy
$170.84 /

+7.48 (+4.58%)

06/02/21 Stifel
Etsy 'smartly expanding' with Depop acquisition, says Stifel
05/10/21 Citi
Etsy price target lowered to $245 from $260 at Citi
05/07/21 Stifel
Etsy upgraded to Buy from Hold at Stifel
05/06/21 Canaccord
Etsy recent selloff an attractive buying opportunity, says Canaccord
MOR MorphoSys
$19.34 /

-2.8 (-12.65%)

05/24/21 Morgan Stanley
Morgan Stanley upgrades MorphoSys with shares near 'bear case value'
05/24/21 Morgan Stanley
MorphoSys upgraded to Overweight from Equal Weight at Morgan Stanley
05/21/21 JPMorgan
MorphoSys price target lowered to EUR 105 from EUR 110 at JPMorgan
04/08/21 Deutsche Bank
MorphoSys price target lowered to EUR 116 from EUR 129 at Deutsche Bank
CNST Constellation Pharmaceuticals
$33.74 /

+13.49 (+66.62%)

01/25/21 BMO Capital
Constellation Pharmaceuticals upgraded to Outperform at BMO Capital
01/25/21 BMO Capital
Constellation upgraded to Outperform from Market Perform at BMO Capital
10/30/20 JPMorgan
Constellation added to Analyst Focus List at JPMorgan
09/08/20 Oppenheimer
Constellation Pharmaceuticals downgraded to Perform at Oppenheimer
TM Toyota
$176.43 /

+4.05 (+2.35%)

03/30/21 Citi
Toyota resumed with a Buy at Citi
09/14/20 Credit Suisse
Toyota upgraded to Outperform from Neutral at Credit Suisse
09/08/20 Bernstein
Bernstein sees Tesla's current valuation as 'mind-boggling'
07/29/20 Morgan Stanley
Tesla price target raised to $1,050 from $740 at Morgan Stanley
TSLA Tesla
$607.33 /

-16.42 (-2.63%)

05/24/21
Fly Intel: Top five analyst initiations
05/24/21 Wells Fargo
Tesla initiated with an Equal Weight at Wells Fargo
05/21/21 BofA
Tesla price target lowered to $700 from $900 at BofA
05/18/21 New Street
New Street would be buyers of Tesla amid current selloff
MDLA Medallia
$28.27 /

+3.215 (+12.83%)

06/02/21 BTIG
Medallia price target lowered to $42 from $49 at BTIG
06/02/21 Craig-Hallum
Medallia price target lowered to $35 from $44 at Craig-Hallum
06/02/21 BofA
Medallia price target lowered to $43 from $49 at BofA
06/02/21 Citi
Medallia price target lowered to $50 from $59 at Citi
ITI Iteris
$7.21 /

+0.01 (+0.14%)

03/02/21 Northland
Rekor unlikely to increase offer for Iteris, says Northland
12/08/20 B. Riley
Iteris price target raised to $9 from $8.50 at B. Riley Securities
ZM Zoom Video
$327.85 /

+0.03 (+0.01%)

06/02/21 JPMorgan
Zoom Video price target lowered to $385 from $456 at JPMorgan
06/02/21 Morgan Stanley
Zoom Video churn overhang keeps near-term ceiling on shares, says Morgan Stanley
06/02/21 BTIG
Zoom Video price target lowered to $495 from $550 at BTIG
06/02/21 Deutsche Bank
Zoom Video price target raised to $375 from $360 at Deutsche Bank
HPE HP Enterprise
$15.96 /

-0.12 (-0.75%)

06/02/21 Loop Capital
HP Enterprise price target raised to $15 from $11 at Loop Capital
06/02/21 Stifel
HP Enterprise guidance reflects supply constraints, says Stifel
06/02/21 Deutsche Bank
HP Enterprise price target raised to $18 from $17 at Deutsche Bank
06/02/21 Barclays
HP Enterprise price target raised to $16 from $15 at Barclays
PROG Progenity
$2.37 /

-0.48 (-16.84%)

05/14/21 Baird
Progenity price target lowered to $4 from $6 at Baird
05/03/21 Piper Sandler
Progenity shares do not reflect upcoming catalysts, says Piper Sandler
03/19/21 Piper Sandler
Progenity has multiple catalysts in 2021, says Piper Sandler
02/08/21 Wells Fargo
Progenity downgraded to Underweight from Overweight at Wells Fargo
SKLZ Skillz
$19.60 /

+2.615 (+15.40%)

05/21/21 Citi
Skillz price target lowered to $23 from $27 at Citi
05/06/21 Wells Fargo
Skillz price target lowered to $18.50 from $28 at Wells Fargo
05/05/21 Canaccord
Skillz price target lowered to $30 from $33 at Canaccord
05/05/21 Canaccord
Skillz price target lowered to $30 from $33 at Canaccord
BBBY Bed Bath & Beyond
$37.98 /

+10.735 (+39.40%)

05/18/21 Credit Suisse
Bed Bath & Beyond assumed with a Neutral at Credit Suisse
04/19/21 JPMorgan
Bed Bath & Beyond price target raised to $29 from $23 at JPMorgan
04/16/21 Loop Capital
Bed Bath & Beyond price target lowered to $24 from $30 at Loop Capital
04/15/21 Wedbush
Bed Bath & Beyond price target lowered to $27 from $33 at Wedbush
WPRT Westport
$6.13 /

-0.62 (-9.19%)

03/18/21 Lake Street
Lake Street confidence in Westport's China ramp boosted by Weichai deal
03/17/21 H.C. Wainwright
Westport price target raised to $16 from $5 at H.C. Wainwright
02/08/21 Craig-Hallum
Clean Energy price target raised to $25 from $12 at Craig-Hallum
02/08/21 Craig-Hallum
Westport target raised to $24 following Amazon truck order, says Craig-Hallum
SESN Sesen Bio
$3.69 /

-0.175 (-4.53%)

02/17/21 Canaccord
Sesen Bio price target raised to $7 from $5 at Canaccord
02/16/21 Canaccord
Sesen Bio price target raised to $7 from $5 at Canaccord
02/16/21 Jefferies
Jefferies doubles target on Sesen Bio to $6 on 'optimal scenario'
01/25/21 Canaccord
Sesen Bio a must-own small cap for 2021, says Canaccord
IRTC iRhythm
$63.51 /

-12.69 (-16.65%)

06/02/21 Citi
iRhythm downgraded to Neutral from Buy at Citi
04/14/21 Morgan Stanley
iRhythm downgraded to Equal Weight from Overweight at Morgan Stanley
04/13/21 Truist
iRhythm price target lowered to $115 from $220 at Truist
04/13/21 BTIG
iRhythm downgraded to Neutral from Buy at BTIG
CNK Cinemark
$23.24 /

-1.18 (-4.83%)

06/02/21 Goldman Sachs
Cinemark downgraded to Sell from Neutral at Goldman Sachs
04/19/21 Morgan Stanley
Cinemark price target raised to $25 from $17 at Morgan Stanley
03/24/21 B. Riley
Disney 'day-and-date' decision negative for exhibitors, says B. Riley
03/03/21 Barrington
Cinemark price target raised to $26 from $22 at Barrington
IMAX Imax
$21.62 /

-0.665 (-2.98%)

06/02/21
Fly Intel: Top five analyst downgrades
06/02/21 Goldman Sachs
Imax downgraded to Sell from Neutral at Goldman Sachs
05/24/21 Benchmark
Imax price target raised to $25 at Benchmark after F9's opening weekend
04/30/21 Macquarie
Imax price target raised to $30 from $25 at Macquarie
HNST Honest Company
$17.82 /

+0.97 (+5.76%)

06/02/21 BofA
Honest Company initiated with a Neutral at BofA
06/01/21
Fly Intel: Top five analyst initiations
06/01/21 William Blair
Honest Company initiated with an Outperform at William Blair
06/01/21 Jefferies
Honest Company initiated with a Buy at Jefferies
VMEO Vimeo
$42.80 /

-0.04 (-0.09%)

06/02/21
Fly Intel: Top five analyst initiations
06/02/21 Cowen
Cowen sees Vimeo as rising video SaaS star, starts with Outperform
06/02/21 Cowen
Vimeo initiated with an Outperform at Cowen
06/02/21 Jefferies
Vimeo initiated with a Buy at Jefferies
CGC Canopy Growth
$25.39 /

+1.08 (+4.44%)

06/02/21 CIBC
Canopy Growth price target lowered to C$36 from C$38 at CIBC
06/02/21
Fly Intel: Top five analyst upgrades
06/02/21 MKM Partners
Canopy Growth price target lowered to C$51 from C$55 at MKM Partners
06/02/21 Eight Capital
Canopy Growth upgraded to Neutral from Sell at Eight Capital
OSTK Overstock.com
$88.12 /

+2.47 (+2.88%)

05/18/21 Credit Suisse
Overstock.com assumed with an Outperform at Credit Suisse
05/18/21 Piper Sandler
Overstock.com holders getting tZero upside 'for free,' says Piper Sandler
04/27/21 Piper Sandler
Overstock.com shares still mispriced with 100% upside, says Piper Sandler
04/14/21 Wedbush
Wedbush bullish on Overstock.com, assumes coverage with an Outperform
MSFT Microsoft
$248.34 /

+1.075 (+0.43%)

06/01/21 KGI Securities
Microsoft initiated with an Outperform at KGI Securities
05/27/21 UBS
Zoom Video initiated with a Neutral at UBS
05/26/21 Wedbush
Microsoft cloud story not slowing down, says Wedbush
05/18/21 Jefferies
Microsoft price target lowered to $290 from $300 at Jefferies
DLB Dolby
$96.01 /

-0.5 (-0.52%)

05/26/21 Tigress Financial
Tigress sees Dolby shares hitting $128 over next 12 months
01/29/21 B. Riley
Dolby price target raised to $89 from $79 at B. Riley Securities
01/04/21 Barrington
Dolby downgraded to Market Perform on valuation at Barrington
01/04/21 Barrington
Dolby downgraded to Market Perform from Outperform at Barrington
CS Credit Suisse
$11.10 /

-0.04 (-0.36%)

05/27/21 Barclays
Credit Suisse price target raised to CHF 12.50 from CHF 12 at Barclays
04/28/21 UBS
Credit Suisse upgraded to Buy from Neutral at UBS
04/28/21 UBS
Credit Suisse upgraded to Buy from Neutral at UBS
04/23/21 Societe Generale
Credit Suisse price target lowered to CHF 10 from CHF 11 at Societe Generale
SFTBY SoftBank
$37.23 /

-0.94 (-2.46%)

04/20/21 Citi
Nvidia deal for Arm has only 10% chance of closing, says Citi
03/11/21 Jefferies
SoftBank downgraded to Hold from Buy at Jefferies
03/10/21 Morgan Stanley
SoftBank resumed with an Equal Weight at Morgan Stanley
11/27/20 Citi
SoftBank price target raised to 11,000 yen from 10,200 yen at Citi
ZM Zoom Video
$327.85 /

+0.03 (+0.01%)

WPRT Westport
$6.13 /

-0.62 (-9.19%)

TSLA Tesla
$607.33 /

-16.42 (-2.63%)

TM Toyota
$176.43 /

+4.05 (+2.35%)

SKLZ Skillz
$19.60 /

+2.615 (+15.40%)

SESN Sesen Bio
$3.69 /

-0.175 (-4.53%)

PROG Progenity
$2.37 /

-0.48 (-16.84%)

OSTK Overstock.com
$88.12 /

+2.47 (+2.88%)

MSFT Microsoft
$248.34 /

+1.075 (+0.43%)

MDLA Medallia
$28.27 /

+3.215 (+12.83%)

ITI Iteris
$7.21 /

+0.01 (+0.14%)

IRTC iRhythm
$63.51 /

-12.69 (-16.65%)

IMAX Imax
$21.62 /

-0.665 (-2.98%)

HPE HP Enterprise
$15.96 /

-0.12 (-0.75%)

ETSY Etsy
$170.84 /

+7.48 (+4.58%)

DLB Dolby
$96.01 /

-0.5 (-0.52%)

CS Credit Suisse
$11.10 /

-0.04 (-0.36%)

CNST Constellation Pharmaceuticals
$33.74 /

+13.49 (+66.62%)

CNK Cinemark
$23.24 /

-1.18 (-4.83%)

CGC Canopy Growth
$25.39 /

+1.08 (+4.44%)

BBBY Bed Bath & Beyond
$37.98 /

+10.735 (+39.40%)

AMZN Amazon.com
$3,231.95 /

+12.67 (+0.39%)

  • 03
    Jun
  • 05
    May
  • 19
    Mar
  • 13
    Jan
  • 03
    Dec
  • 19
    Aug
  • 12
    Aug
  • 17
    Jun
  • 19
    Jun
ZM Zoom Video
$327.85 /

+0.03 (+0.01%)

WPRT Westport
$6.13 /

-0.62 (-9.19%)

TSLA Tesla
$607.33 /

-16.42 (-2.63%)

TM Toyota
$176.43 /

+4.05 (+2.35%)

SKLZ Skillz
$19.60 /

+2.615 (+15.40%)

SFTBY SoftBank
$37.23 /

-0.94 (-2.46%)

OSTK Overstock.com
$88.12 /

+2.47 (+2.88%)

MSFT Microsoft
$248.34 /

+1.075 (+0.43%)

IRTC iRhythm
$63.51 /

-12.69 (-16.65%)

IMAX Imax
$21.62 /

-0.665 (-2.98%)

HPE HP Enterprise
$15.96 /

-0.12 (-0.75%)

HNST Honest Company
$17.82 /

+0.97 (+5.76%)

ETSY Etsy
$170.84 /

+7.48 (+4.58%)

CS Credit Suisse
$11.10 /

-0.04 (-0.36%)

CNK Cinemark
$23.24 /

-1.18 (-4.83%)

CGC Canopy Growth
$25.39 /

+1.08 (+4.44%)

BBBY Bed Bath & Beyond
$37.98 /

+10.735 (+39.40%)

AMZN Amazon.com
$3,231.95 /

+12.67 (+0.39%)

ZM Zoom Video
$327.85 /

+0.03 (+0.01%)

WPRT Westport
$6.13 /

-0.62 (-9.19%)

VMEO Vimeo
$42.80 /

-0.04 (-0.09%)

TSLA Tesla
$607.33 /

-16.42 (-2.63%)

TM Toyota
$176.43 /

+4.05 (+2.35%)

SKLZ Skillz
$19.60 /

+2.615 (+15.40%)

SFTBY SoftBank
$37.23 /

-0.94 (-2.46%)

SESN Sesen Bio
$3.69 /

-0.175 (-4.53%)

PROG Progenity
$2.37 /

-0.48 (-16.84%)

OSTK Overstock.com
$88.12 /

+2.47 (+2.88%)

MSFT Microsoft
$248.34 /

+1.075 (+0.43%)

MOR MorphoSys
$19.34 /

-2.8 (-12.65%)

MDLA Medallia
$28.27 /

+3.215 (+12.83%)

IRTC iRhythm
$63.51 /

-12.69 (-16.65%)

IMAX Imax
$21.62 /

-0.665 (-2.98%)

HPE HP Enterprise
$15.96 /

-0.12 (-0.75%)

HNST Honest Company
$17.82 /

+0.97 (+5.76%)

ETSY Etsy
$170.84 /

+7.48 (+4.58%)

DLB Dolby
$96.01 /

-0.5 (-0.52%)

CS Credit Suisse
$11.10 /

-0.04 (-0.36%)

CNK Cinemark
$23.24 /

-1.18 (-4.83%)

CGC Canopy Growth
$25.39 /

+1.08 (+4.44%)

BBBY Bed Bath & Beyond
$37.98 /

+10.735 (+39.40%)

AMZN Amazon.com
$3,231.95 /

+12.67 (+0.39%)

ZM Zoom Video
$327.85 /

+0.03 (+0.01%)

WPRT Westport
$6.13 /

-0.62 (-9.19%)

TSLA Tesla
$607.33 /

-16.42 (-2.63%)

TM Toyota
$176.43 /

+4.05 (+2.35%)

SKLZ Skillz
$19.60 /

+2.615 (+15.40%)

PROG Progenity
$2.37 /

-0.48 (-16.84%)

OSTK Overstock.com
$88.12 /

+2.47 (+2.88%)

MSFT Microsoft
$248.34 /

+1.075 (+0.43%)

IMAX Imax
$21.62 /

-0.665 (-2.98%)

HPE HP Enterprise
$15.96 /

-0.12 (-0.75%)

HNST Honest Company
$17.82 /

+0.97 (+5.76%)

ETSY Etsy
$170.84 /

+7.48 (+4.58%)

CS Credit Suisse
$11.10 /

-0.04 (-0.36%)

CNK Cinemark
$23.24 /

-1.18 (-4.83%)

CGC Canopy Growth
$25.39 /

+1.08 (+4.44%)

BBBY Bed Bath & Beyond
$37.98 /

+10.735 (+39.40%)

AMZN Amazon.com
$3,231.95 /

+12.67 (+0.39%)

Hot Stocks
Sesen Bio announces global supply partnership with Qilu Pharmaceutical » 08:19
06/02/21
06/02
08:19
06/02/21
08:19
SESN

Sesen Bio

$3.86 /

+0.52 (+15.57%)

Sesen Bio announced that…

Sesen Bio announced that on Tuesday, June 1, 2021 the vompany entered into a global supply agreement for Vicineum drug substance and drug product with the company's partner in China, Qilu Pharmaceutical. Under the terms of the global supply agreement, Qilu Pharmaceutical will be part of the manufacturing network for global commercial supply of Vicineum drug substance and drug product. In February 2021, the U.S. Food and Drug Administration accepted for filing the company's Biologics License Application for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer and granted the application Priority Review, with a target Prescription Drug User Fee Act date of August 18, 2021. The company anticipates initiating promotion to physicians and patients in the US upon approval, with commercial product supply broadly available to urology clinics by the fourth quarter of 2021. The new global supply agreement with Qilu Pharmaceutical builds on the company's existing partnership by setting specific terms such as capacity, forecasts, pricing and product delivery. The completion of the global supply agreement expands the Company's network of world-class partners committed to providing reliable supply of Vicineum worldwide. Sesen Bio is entitled to a $2M milestone payment upon completion of technology transfer to Qilu Pharmaceutical, which the company believes is on track for completion in 2021. Sesen Bio also continues to support Qilu Pharmaceutical in the development and commercialization of Vicineum in China. In March 2021, the Investigational New Drug application for Vicineum was approved by the Center for Drug Evaluation of the China National Medical Products Administration thereby triggering a $3M milestone payment to Sesen Bio, which the Company received, net of taxes, on May 24, 2021. The approval of the IND enables Qilu Pharmaceutical to conduct the proposed clinical trial to assess the efficacy and safety of Vicineum for patients in China. It is anticipated that the first patient will be dosed in the trial within the next month. Assuming a successful trial, Qilu Pharmaceutical anticipates submission of the product market application for Vicineum in 2022 with potential approval in China expected in 2023.

ShowHide Related Items >><<
SESN Sesen Bio
$3.86 /

+0.52 (+15.57%)

SESN Sesen Bio
$3.86 /

+0.52 (+15.57%)

02/17/21 Canaccord
Sesen Bio price target raised to $7 from $5 at Canaccord
02/16/21 Canaccord
Sesen Bio price target raised to $7 from $5 at Canaccord
02/16/21 Jefferies
Jefferies doubles target on Sesen Bio to $6 on 'optimal scenario'
01/25/21 Canaccord
Sesen Bio a must-own small cap for 2021, says Canaccord
SESN Sesen Bio
$3.86 /

+0.52 (+15.57%)

SESN Sesen Bio
$3.86 /

+0.52 (+15.57%)

Hot Stocks
Sesen Bio announces expansion of its senior leadership team » 08:59
06/01/21
06/01
08:59
06/01/21
08:59
SESN

Sesen Bio

$3.34 /

+0.185 (+5.86%)

, MRK

Merck

$75.90 /

-0.01 (-0.01%)

, URGN

UroGen Pharma

$17.71 /

-0.61 (-3.33%)

Sesen Bio (SESN)…

Sesen Bio (SESN) announced the expansion of its senior leadership team with the appointment of experienced industry leaders to several key roles: Patricia Drake to Chief Commercial Officer; Steve Barbera to Vice President, Market Access; Julie Hoff to Vice President, Human Resources; and Dewey McLin to Vice President, Medical Affairs. Patricia Drake is a seasoned biopharma executive with over 30 years of experience. Prior to joining Sesen Bio, Drake spent her career at Merck (MRK). Prior to joining Sesen Bio, Barbera served as the Vice President of Market Access at UroGen Pharma (URGN) and played a role in the launch of the company's first commercial product, Jelmyto. Prior to joining Sesen Bio, Ms. Hoff served as Director of Human Resources at Core & Main where she led various initiatives across talent management, M&A, and employee engagement and retention. Prior to joining Sesen Bio, McLin was Sr. Director of Medical Affairs and a Product Development Team lead at Greenwich Biosciences, where he played a role in the successful commercialization of the first cannabis-based product approved by the FDA to treat rare forms of epilepsy.

ShowHide Related Items >><<
URGN UroGen Pharma
$17.71 /

-0.61 (-3.33%)

SESN Sesen Bio
$3.34 /

+0.185 (+5.86%)

MRK Merck
$75.90 /

-0.01 (-0.01%)

SESN Sesen Bio
$3.34 /

+0.185 (+5.86%)

02/17/21 Canaccord
Sesen Bio price target raised to $7 from $5 at Canaccord
02/16/21 Canaccord
Sesen Bio price target raised to $7 from $5 at Canaccord
02/16/21 Jefferies
Jefferies doubles target on Sesen Bio to $6 on 'optimal scenario'
01/25/21 Canaccord
Sesen Bio a must-own small cap for 2021, says Canaccord
MRK Merck
$75.90 /

-0.01 (-0.01%)

05/20/21
Fly Intel: Top five analyst downgrades
05/20/21 Argus
Merck downgraded to Hold at Argus ahead of Organon spinoff
05/20/21 Argus
Merck downgraded to Hold from Buy at Argus
05/05/21 BTIG
Mereo BioPharma initiated with a Buy at BTIG
URGN UroGen Pharma
$17.71 /

-0.61 (-3.33%)

04/27/21 H.C. Wainwright
UroGen Pharma price target lowered to $50 from $57 at H.C. Wainwright
11/10/20 Oppenheimer
UroGen Pharma price target lowered to $40 from $48 at Oppenheimer
09/21/20 JPMorgan
UroGen Pharma price target lowered to $26 from $31 at JPMorgan
URGN UroGen Pharma
$17.71 /

-0.61 (-3.33%)

SESN Sesen Bio
$3.34 /

+0.185 (+5.86%)

MRK Merck
$75.90 /

-0.01 (-0.01%)

MRK Merck
$75.90 /

-0.01 (-0.01%)

SESN Sesen Bio
$3.34 /

+0.185 (+5.86%)

MRK Merck
$75.90 /

-0.01 (-0.01%)

MRK Merck
$75.90 /

-0.01 (-0.01%)

Over a month ago
Earnings
Sesen Bio reports Q1 EPS (35c), consensus (8c) » 07:37
05/10/21
05/10
07:37
05/10/21
07:37
SESN

Sesen Bio

$2.68 /

+0.06 (+2.29%)

Cash, cash equivalents…

Cash, cash equivalents and restricted cash were $110 million as of March 31, 2021, compared to $55.4 million as of December 31, 2020. "We are very pleased with the tremendous progress we continue to make in our four biggest global markets: the US, Europe, the Middle East and North Africa region and China," said Dr. Thomas Cannell, president and chief executive officer of Sesen Bio. "In the US, we continue to work with the FDA as we approach our target PDUFA date, and we are making substantial progress toward launch readiness. We are laser focused on bringing a product to market that we believe will improve patient outcomes while reducing overall healthcare costs to patients globally, and we expect to continue to make progress around the world in the coming months."

ShowHide Related Items >><<
SESN Sesen Bio
$2.68 /

+0.06 (+2.29%)

SESN Sesen Bio
$2.68 /

+0.06 (+2.29%)

02/17/21 Canaccord
Sesen Bio price target raised to $7 from $5 at Canaccord
02/16/21 Canaccord
Sesen Bio price target raised to $7 from $5 at Canaccord
02/16/21 Jefferies
Jefferies doubles target on Sesen Bio to $6 on 'optimal scenario'
01/25/21 Canaccord
Sesen Bio a must-own small cap for 2021, says Canaccord
SESN Sesen Bio
$2.68 /

+0.06 (+2.29%)

SESN Sesen Bio
$2.68 /

+0.06 (+2.29%)

Conference/Events
Canaccord to hold a virtual conference » 09:39
04/15/21
04/15
09:39
04/15/21
09:39
ONCY

Oncolytics

$3.06 /

-0.08 (-2.55%)

, SESN

Sesen Bio

$2.35 /

+0.015 (+0.64%)

, OLMA

Olema Oncology

$35.84 /

+3.56 (+11.03%)

, SQZ

SQZ Biotechnologies

$13.06 /

-0.12 (-0.91%)

, APTO

Aptose Biosciences

$5.20 /

+0.09 (+1.76%)

, BCEL

Atreca

$12.42 /

+0.83 (+7.16%)

, BNTX

BioNTech

$132.52 /

+3.11 (+2.40%)

Horizons in Oncology…

Horizons in Oncology Virtual Conference to be held on April 15.

ShowHide Related Items >><<
SQZ SQZ Biotechnologies
$13.06 /

-0.12 (-0.91%)

SESN Sesen Bio
$2.35 /

+0.015 (+0.64%)

ONCY Oncolytics
$3.06 /

-0.08 (-2.55%)

OLMA Olema Oncology
$35.84 /

+3.56 (+11.03%)

BNTX BioNTech
$132.52 /

+3.11 (+2.40%)

APTO Aptose Biosciences
$5.20 /

+0.09 (+1.76%)

ONCY Oncolytics
$3.06 /

-0.08 (-2.55%)

02/17/21 H.C. Wainwright
Oncolytics initiated with a Buy at H.C. Wainwright
05/11/20 RBC Capital
Oncolytics price target lowered to C$6 from C$9 at RBC Capital
SESN Sesen Bio
$2.35 /

+0.015 (+0.64%)

02/17/21 Canaccord
Sesen Bio price target raised to $7 from $5 at Canaccord
02/16/21 Canaccord
Sesen Bio price target raised to $7 from $5 at Canaccord
02/16/21 Jefferies
Jefferies doubles target on Sesen Bio to $6 on 'optimal scenario'
01/25/21 Canaccord
Sesen Bio a must-own small cap for 2021, says Canaccord
OLMA Olema Oncology
$35.84 /

+3.56 (+11.03%)

12/14/20 JPMorgan
Olema Oncology initiated with an Overweight at JPMorgan
12/14/20 Jefferies
Olema Pharmaceuticals initiated with a Buy at Jefferies
12/14/20 Canaccord
Olema Pharmaceuticals initiated with a Buy at Canaccord
12/14/20 Cowen
Olema Pharmaceuticals initiated with an Outperform at Cowen
SQZ SQZ Biotechnologies
$13.06 /

-0.12 (-0.91%)

03/30/21 Brookline
SQZ Biotechnologies initiated with a Buy at Brookline
01/07/21 Evercore ISI
SQZ Biotechnologies initiated with an Outperform at Evercore ISI
11/24/20 Stifel
SQZ Biotechnologies initiated with a Buy at Stifel
11/24/20 BofA
SQZ Biotechnologies initiated with a Buy at BofA
APTO Aptose Biosciences
$5.20 /

+0.09 (+1.76%)

02/22/21 JonesTrading
Aptose Biosciences resumed with a Buy at JonesTrading
10/19/20 Cantor Fitzgerald
Aptose Biosciences initiated with an Overweight at Cantor Fitzgerald
09/22/20 Alliance Global Partners
Aptose Biosciences initiated with a Buy at Alliance Global Partners
09/18/20 Piper Sandler
Piper Sandler lays out next potential takeover targets in oncology
BCEL Atreca
$12.42 /

+0.83 (+7.16%)

02/08/21 Jefferies
Atreca initiated with a Buy at Jefferies
08/12/20 Stifel
Volatility in Atreca shares creates 'interesting' opportunity, says Stifel
07/08/20 Piper Sandler
Xencor, Atreca deal offers synergies for XmAb design, says Piper Sandler
07/01/20 Canaccord
Atreca price target raised to $33 from $23 at Canaccord
BNTX BioNTech
$132.52 /

+3.11 (+2.40%)

02/23/21 B. Riley
B. Riley remains 'aggressive' buyer of Novavax after updated FDA guidance
02/01/21 SVB Leerink
Moderna price target raised to $80 from $69 at SVB Leerink
01/29/21 Piper Sandler
Moderna, Pfizer keep Covid vaccine competitive advantage, says Piper Sandler
01/14/21 Morgan Stanley
80%+ efficacy from J&J vaccine would be 'compelling,' says Morgan Stanley
SESN Sesen Bio
$2.35 /

+0.015 (+0.64%)

ONCY Oncolytics
$3.06 /

-0.08 (-2.55%)

OLMA Olema Oncology
$35.84 /

+3.56 (+11.03%)

BCEL Atreca
$12.42 /

+0.83 (+7.16%)

APTO Aptose Biosciences
$5.20 /

+0.09 (+1.76%)

  • 12
    Feb
  • 19
    Nov
  • 30
    Oct
  • 23
    Jul
  • 16
    Jul
  • 16
    Jul
BNTX BioNTech
$132.52 /

+3.11 (+2.40%)

SQZ SQZ Biotechnologies
$13.06 /

-0.12 (-0.91%)

SESN Sesen Bio
$2.35 /

+0.015 (+0.64%)

OLMA Olema Oncology
$35.84 /

+3.56 (+11.03%)

BNTX BioNTech
$132.52 /

+3.11 (+2.40%)

APTO Aptose Biosciences
$5.20 /

+0.09 (+1.76%)

OLMA Olema Oncology
$35.84 /

+3.56 (+11.03%)

BNTX BioNTech
$132.52 /

+3.11 (+2.40%)

Hot Stocks
Sesen Bio says independent proxy firms recommend voting for proposal » 08:20
04/07/21
04/07
08:20
04/07/21
08:20
SESN

Sesen Bio

$2.71 /

-0.055 (-1.99%)

Sesen Bio announced that …

Sesen Bio announced that independent proxy advisory firms Institutional Shareholder Services, and Glass, Lewis have both recommended Sesen Bio's stockholders vote for the proposal to increase the number of authorized shares of common stock by 200M .ISS and Glass Lewis are widely recognized as leading independent voting advisory firms. Their impartial analyses and reports are developed with the objective of delivering transparency to help investors make informed investment decisions. Notably, ISS stated in its report that support for Proposal 2 is warranted given that the proposed increase in the number of authorized shares is reasonable and that there is a specific and severe risk to stockholders if Proposal 2 is not approved. Glass Lewis also concluded in its report that the proposed increase in the number of authorized shares is reasonable, citing the relatively limited amount of shares currently available to the Company . As part of its methodology, Glass Lewis undertakes an analysis to ensure that the additional shares are truly needed.

ShowHide Related Items >><<
SESN Sesen Bio
$2.71 /

-0.055 (-1.99%)

SESN Sesen Bio
$2.71 /

-0.055 (-1.99%)

02/17/21 Canaccord
Sesen Bio price target raised to $7 from $5 at Canaccord
02/16/21 Canaccord
Sesen Bio price target raised to $7 from $5 at Canaccord
02/16/21 Jefferies
Jefferies doubles target on Sesen Bio to $6 on 'optimal scenario'
01/25/21 Canaccord
Sesen Bio a must-own small cap for 2021, says Canaccord
SESN Sesen Bio
$2.71 /

-0.055 (-1.99%)

SESN Sesen Bio
$2.71 /

-0.055 (-1.99%)

Hot Stocks
Sesen Bio, Qilu Pharmaceutical announce approval of Vicineum IND in China » 08:06
03/22/21
03/22
08:06
03/22/21
08:06
SESN

Sesen Bio

$3.25 /

+0.195 (+6.39%)

Sesen Bio announced that…

Sesen Bio announced that the Investigational New Drug application for Vicineum for the treatment of BCG-unresponsive non-muscle invasive bladder cancer submitted to the Center for Drug Evaluation of the China National Medical Products Administration by the company's partner in China, Qilu Pharmaceutical, was approved ahead of the original timeline of April 2021. With approval of the IND, Qilu Pharmaceutical is authorized to conduct the proposed clinical trial to assess the efficacy and safety of Vicineum in patients with BCG-unresponsive NMIBC in China, at the sole cost of Qilu Pharmaceutical. Assuming a successful trial, Qilu Pharmaceutical anticipates submission of the product market application for Vicineum in 2022 with potential approval in China expected in 2023. "The approval of the IND for Vicineum in China represents a significant milestone in realizing our mission to save and improve the lives of patients globally," said Dr. Thomas Cannell, president and chief executive officer of Sesen Bio. "Due to more limited use of BCG in China compared to the US, there is an opportunity to transform the treatment paradigm of NMIBC in China. The approval of the IND ahead of the original timeline underscores the strong collaboration between Sesen Bio and our partner, Qilu Pharmaceutical. Given the highly experienced clinical oncology team at Qilu Pharmaceutical, and the Phase 3 trial results achieved in the US, we are optimistic on the prospects for a successful trial and expeditious submission. We look forward to continuing to work with Qilu Pharmaceutical and the NMPA to bring this potentially best-in-class treatment to patients in China." Sesen Bio is entitled to receive a $3M milestone payment from Qilu Pharmaceutical, the first of $23M in potential milestone payments. Additionally, the company anticipates Qilu Pharmaceutical will become a key strategic partner for global supply of Vicineum and the manufacturing technology transfer to Qilu Pharmaceutical is on track to be completed in mid-2021. The completion of the manufacturing technology transfer triggers an additional $2M milestone payment.

ShowHide Related Items >><<
SESN Sesen Bio
$3.25 /

+0.195 (+6.39%)

SESN Sesen Bio
$3.25 /

+0.195 (+6.39%)

02/17/21 Canaccord
Sesen Bio price target raised to $7 from $5 at Canaccord
02/16/21 Canaccord
Sesen Bio price target raised to $7 from $5 at Canaccord
02/16/21 Jefferies
Jefferies doubles target on Sesen Bio to $6 on 'optimal scenario'
01/25/21 Canaccord
Sesen Bio a must-own small cap for 2021, says Canaccord
SESN Sesen Bio
$3.25 /

+0.195 (+6.39%)

SESN Sesen Bio
$3.25 /

+0.195 (+6.39%)

Over a quarter ago
On The Fly
Fly Intel: Pre-market Movers » 09:07
03/15/21
03/15
09:07
03/15/21
09:07
BTAI

BioXcel Therapeutics

$46.89 /

-0.53 (-1.12%)

, AMC

AMC Entertainment

$11.13 /

+0.8601 (+8.37%)

, X

U.S. Steel

$24.16 /

+1.83 (+8.20%)

, GNMK

GenMark

$18.55 /

+0.11 (+0.60%)

, PENN

Penn National

$130.49 /

-0.44 (-0.34%)

, GNRC

Generac

$329.59 /

-1.86 (-0.56%)

, CZR

Caesars

$100.62 /

-0.06 (-0.06%)

, DM

Desktop Metal

$20.45 /

-0.1 (-0.49%)

, SESN

Sesen Bio

$2.87 /

+0.16 (+5.90%)

, ACEL

Accel Entertainment

$12.24 /

+0.19 (+1.58%)

, DKNG

DraftKings

$71.78 /

+0.17 (+0.24%)

, LLY

Eli Lilly

$208.12 /

+2.96 (+1.44%)

, RUBY

Rubius Therapeutics

$16.42 /

+0.58 (+3.66%)

, VIAC

ViacomCBS

$94.91 /

+8.64 (+10.02%)

, VIACA

ViacomCBS

$94.72 /

+8.35 (+9.67%)

, RHHBY

Roche

$0.00 /

+ (+0.00%)

Check out this morning's…

ShowHide Related Items >><<
X U.S. Steel
$24.16 /

+1.83 (+8.20%)

VIACA ViacomCBS
$94.72 /

+8.35 (+9.67%)

VIAC ViacomCBS
$94.91 /

+8.64 (+10.02%)

SESN Sesen Bio
$2.87 /

+0.16 (+5.90%)

RUBY Rubius Therapeutics
$16.42 /

+0.58 (+3.66%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PENN Penn National
$130.49 /

-0.44 (-0.34%)

LLY Eli Lilly
$208.12 /

+2.96 (+1.44%)

GNRC Generac
$329.59 /

-1.86 (-0.56%)

GNMK GenMark
$18.55 /

+0.11 (+0.60%)

DM Desktop Metal
$20.45 /

-0.1 (-0.49%)

DKNG DraftKings
$71.78 /

+0.17 (+0.24%)

CZR Caesars
$100.62 /

-0.06 (-0.06%)

BTAI BioXcel Therapeutics
$46.89 /

-0.53 (-1.12%)

AMC AMC Entertainment
$11.13 /

+0.8601 (+8.37%)

ACEL Accel Entertainment
$12.24 /

+0.19 (+1.58%)

BTAI BioXcel Therapeutics
$46.89 /

-0.53 (-1.12%)

02/01/21 UBS
BioXcel Therapeutics initiated with a Buy at UBS
01/06/21 H.C. Wainwright
BioXcel Therapeutics price target raised to $185 from $175 at H.C. Wainwright
10/30/20
Fly Intel: Top five analyst initiations
10/30/20 Goldman Sachs
BioXcel Therapeutics initiated with a Buy at Goldman Sachs
AMC AMC Entertainment
$11.13 /

+0.8601 (+8.37%)

03/11/21 B. Riley
AMC Entertainment price target raised to $7 from $5.50 at B. Riley Securities
03/10/21 LightShed Partners
AMC Entertainment initiated with a Sell at LightShed Partners
02/04/21 Citi
Citi sees 'dramatically reduced' bankruptcy risk for AMC Entertainment
02/01/21 MKM Partners
AMC Entertainment downgraded to Sell from Neutral at MKM Partners
X U.S. Steel
$24.16 /

+1.83 (+8.20%)

03/15/21 BMO Capital
U.S. Steel price target raised to $25 from $21 at BMO Capital
03/15/21 Argus
U.S. Steel downgraded to Hold from Buy at Argus
03/15/21 Argus
U.S. Steel downgraded to Hold from Buy at Argus
02/24/21 Argus
U.S. Steel price target raised to $23 from $20 at Argus
GNMK GenMark
$18.55 /

+0.11 (+0.60%)

02/16/21 Canaccord
GenMark price target raised to $24 from $22 at Canaccord
10/09/20 Canaccord
Execution positions GenMark for long-term success, says Canaccord
08/28/20 Canaccord
Hospital service channel shares weakness a buying opportunity, says Canaccord
08/05/20 Canaccord
GenMark price target raised to $22 from $20 at Canaccord
PENN Penn National
$130.49 /

-0.44 (-0.34%)

02/23/21 JPMorgan
JPMorgan ups Penn National target, says don't wait for selloff to buy
02/22/21 Craig-Hallum
Craig-Hallum reiterates $150 target on Penn National after Rush deal
02/09/21 Morgan Stanley
Morgan Stanley says legalized sports betting in Texas this year has 'slim' odds
02/05/21 Truist
Penn National price target raised to $135 from $120 at Truist
GNRC Generac
$329.59 /

-1.86 (-0.56%)

03/08/21 JPMorgan
Generac price target lowered to $340 from $366 at JPMorgan
02/22/21 William Blair
Three companies are well positioned for Texas rebuild, says William Blair
02/16/21 Stifel
Generac price target raised to $340 from $213 at Stifel
02/12/21 JPMorgan
Generac price target raised to $366 from $279 at JPMorgan
CZR Caesars
$100.62 /

-0.06 (-0.06%)

03/03/21 Roth Capital
Golden Entertainment shares worth $40 based on Sands deal, says Roth Capital
03/01/21 KeyBanc
Caesars price target raised to $102 from $89 at KeyBanc
02/26/21 Macquarie
Caesars price target raised to $100 from $86 at Macquarie
02/26/21 Loop Capital
Caesars price target raised to $92 from $82 at Loop Capital
DM Desktop Metal
$20.45 /

-0.1 (-0.49%)

01/29/21 Alliance Global Partners
ExOne upgraded to Buy from Neutral at Alliance Global Partners
01/19/21 Craig-Hallum
Desktop Metal price target raised to $23 from $17 at Craig-Hallum
01/19/21 Stifel
Desktop Metal initiated with a Buy at Stifel
01/08/21 Benchmark
Desktop Metal initiated with a Buy at Benchmark
SESN Sesen Bio
$2.87 /

+0.16 (+5.90%)

02/17/21 Canaccord
Sesen Bio price target raised to $7 from $5 at Canaccord
02/16/21 Canaccord
Sesen Bio price target raised to $7 from $5 at Canaccord
02/16/21 Jefferies
Jefferies doubles target on Sesen Bio to $6 on 'optimal scenario'
01/25/21 Canaccord
Sesen Bio a must-own small cap for 2021, says Canaccord
ACEL Accel Entertainment
$12.24 /

+0.19 (+1.58%)

03/08/21 Macquarie
Accel Entertainment initiated with a Neutral at Macquarie
03/08/21 Macquarie
Accel Entertainment initiated with a Neutral at Macquarie
01/26/21 Goldman Sachs
Accel Entertainment price target raised to $15.50 from $14.50 at Goldman Sachs
09/15/20 Deutsche Bank
Accel Entertainment price target raised to $13 from $11 at Deutsche Bank
DKNG DraftKings
$71.78 /

+0.17 (+0.24%)

03/14/21 Jefferies
FanDuel IPO in U.S. would be 'major catalyst' for Flutter stock, says Jefferies
03/10/21 Jefferies
DraftKings price target raised to $75 from $73 at Jefferies
03/10/21 Susquehanna
DraftKings investor meeting implied conservative guidance, says Susquehanna
03/10/21 Macquarie
DraftKings price target raised to $73 from $71 at Macquarie
LLY Eli Lilly
$208.12 /

+2.96 (+1.44%)

03/15/21 JPMorgan
Eli Lilly Alzheimer's data more mixed than expected, says JPMorgan
03/15/21 Truist
Eli Lilly price target raised to $225 from $215 at Truist
03/15/21 Mizuho
Lilly data not supportive of accelerated Alzheimer's approval, says Mizuho
03/15/21 Citi
Eli Lilly Alzheimer's data falls short of expectations, says Citi
RUBY Rubius Therapeutics
$16.42 /

+0.58 (+3.66%)

10/14/20 JPMorgan
Rubius Therapeutics resumed with a Neutral at JPMorgan
VIAC ViacomCBS
$94.91 /

+8.64 (+10.02%)

03/15/21 BMO Capital
ViacomCBS downgraded to Underperform from Market Perform at BMO Capital
03/12/21 Citi
Citi says 'dangerous to be bearish' on ViacomCBS, boosts target to $92
03/01/21 Cowen
ViacomCBS price target raised to $46 from $39 at Cowen
02/25/21
Fly Intel: Pre-market Movers
VIACA ViacomCBS
$94.72 /

+8.35 (+9.67%)

01/05/21 Gabelli
ViacomCBS named a best idea for 2021 at Gabelli
07/13/20
Fly Intel: Top five analyst initiations
07/13/20
Fly Intel: Top five analyst downgrades
04/07/20 Barrington
ViacomCBS downgraded to Market Perform from Outperform at Barrington
RHHBY Roche
$0.00 /

+ (+0.00%)

03/12/21 Jefferies
Chugai Pharmaceutical downgraded to Hold from Buy at Jefferies
03/11/21 Evercore ISI
Kodiak Sciences initiated with an Outperform at Evercore ISI
03/09/21 Citi
Roche price target lowered to CHF 360 from CHF 385 at Citi
03/05/21 Erste Group
Roche downgraded to Hold from Buy at Erste Group
X U.S. Steel
$24.16 /

+1.83 (+8.20%)

VIAC ViacomCBS
$94.91 /

+8.64 (+10.02%)

SESN Sesen Bio
$2.87 /

+0.16 (+5.90%)

RUBY Rubius Therapeutics
$16.42 /

+0.58 (+3.66%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PENN Penn National
$130.49 /

-0.44 (-0.34%)

LLY Eli Lilly
$208.12 /

+2.96 (+1.44%)

GNRC Generac
$329.59 /

-1.86 (-0.56%)

GNMK GenMark
$18.55 /

+0.11 (+0.60%)

DM Desktop Metal
$20.45 /

-0.1 (-0.49%)

DKNG DraftKings
$71.78 /

+0.17 (+0.24%)

CZR Caesars
$100.62 /

-0.06 (-0.06%)

BTAI BioXcel Therapeutics
$46.89 /

-0.53 (-1.12%)

AMC AMC Entertainment
$11.13 /

+0.8601 (+8.37%)

ACEL Accel Entertainment
$12.24 /

+0.19 (+1.58%)

  • 03
    Feb
  • 07
    Oct
  • 29
    Sep
  • 25
    Sep
  • 24
    Sep
  • 29
    Jul
  • 18
    Jun
  • 19
    Jun
  • 12
    May
  • 07
    May
X U.S. Steel
$24.16 /

+1.83 (+8.20%)

VIACA ViacomCBS
$94.72 /

+8.35 (+9.67%)

VIAC ViacomCBS
$94.91 /

+8.64 (+10.02%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PENN Penn National
$130.49 /

-0.44 (-0.34%)

LLY Eli Lilly
$208.12 /

+2.96 (+1.44%)

GNMK GenMark
$18.55 /

+0.11 (+0.60%)

DKNG DraftKings
$71.78 /

+0.17 (+0.24%)

AMC AMC Entertainment
$11.13 /

+0.8601 (+8.37%)

X U.S. Steel
$24.16 /

+1.83 (+8.20%)

VIAC ViacomCBS
$94.91 /

+8.64 (+10.02%)

RHHBY Roche
$0.00 /

+ (+0.00%)

PENN Penn National
$130.49 /

-0.44 (-0.34%)

LLY Eli Lilly
$208.12 /

+2.96 (+1.44%)

GNRC Generac
$329.59 /

-1.86 (-0.56%)

GNMK GenMark
$18.55 /

+0.11 (+0.60%)

DKNG DraftKings
$71.78 /

+0.17 (+0.24%)

CZR Caesars
$100.62 /

-0.06 (-0.06%)

BTAI BioXcel Therapeutics
$46.89 /

-0.53 (-1.12%)

AMC AMC Entertainment
$11.13 /

+0.8601 (+8.37%)

ACEL Accel Entertainment
$12.24 /

+0.19 (+1.58%)

X U.S. Steel
$24.16 /

+1.83 (+8.20%)

VIAC ViacomCBS
$94.91 /

+8.64 (+10.02%)

PENN Penn National
$130.49 /

-0.44 (-0.34%)

LLY Eli Lilly
$208.12 /

+2.96 (+1.44%)

DM Desktop Metal
$20.45 /

-0.1 (-0.49%)

DKNG DraftKings
$71.78 /

+0.17 (+0.24%)

CZR Caesars
$100.62 /

-0.06 (-0.06%)

AMC AMC Entertainment
$11.13 /

+0.8601 (+8.37%)

Earnings
Sesen Bio reports Q4 EPS (11c), consensus (11c) » 07:06
03/15/21
03/15
07:06
03/15/21
07:06
SESN

Sesen Bio

$2.87 /

+0.16 (+5.90%)

Cash, cash equivalents…

Cash, cash equivalents and restricted cash were $55.4m as of December 31, compared to $48.1m as of December 31, 2019. As of the end of February cash and cash equivalents were $98m. This amount is preliminary and is subject to change upon completion of the Company's financial statements for the quarterly period ended March 31, 2021. "We continue to make tremendous progress on our regulatory path with potential US approval later this year," said Dr. Thomas Cannell, president and chief executive officer of Sesen Bio. "Our talented and growing team is laser-focused on bringing a best-in-class treatment to the market that has the potential to improve patient outcomes while reducing healthcare costs. With a strong balance sheet and clear regulatory path forward in both the US and Europe, we are positioned to fully realize the potentially significant global opportunity for Vicineum. We expect 2021 to be a transformative year for Sesen Bio and the patients we serve."

ShowHide Related Items >><<
SESN Sesen Bio
$2.87 /

+0.16 (+5.90%)

SESN Sesen Bio
$2.87 /

+0.16 (+5.90%)

02/17/21 Canaccord
Sesen Bio price target raised to $7 from $5 at Canaccord
02/16/21 Canaccord
Sesen Bio price target raised to $7 from $5 at Canaccord
02/16/21 Jefferies
Jefferies doubles target on Sesen Bio to $6 on 'optimal scenario'
01/25/21 Canaccord
Sesen Bio a must-own small cap for 2021, says Canaccord
SESN Sesen Bio
$2.87 /

+0.16 (+5.90%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.